<DOC>
	<DOCNO>NCT00625209</DOCNO>
	<brief_summary>This study aim compare efficacy safety recombinant human activate protein C low dose corticosteroid investigate interaction drug management septic shock</brief_summary>
	<brief_title>Activated Protein C Corticosteroids Human Septic Shock</brief_title>
	<detailed_description>Septic shock still place burden healthcare system round around world . In early 20ties , clinical trial suggest potential benefit activate protein C severe sepsis corticosteroid give adult refractory shock . More recent study suggest patient moderate sepsis septic shock may benefit either activated protein C corticosteroid . Therefore , current international guideline suggest physician may consider use drug severe case sepsis . The main risk associate use activate protein C bleeding main risk associate use steroid superinfection . It paramount new adequately powered trial explores benefit/risk ratio two drug combination population adult patient septic shock . After withdrawal Xigris October 2011 , study suspend restart June 2012 investigate benefit risk ratio corticosteroid .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Fludrocortisone</mesh_term>
	<mesh_term>Protein C</mesh_term>
	<mesh_term>Drotrecogin alfa activate</mesh_term>
	<criteria>hospitalize intensive care unit le 7 day septic shock le 24 hour least one proven site infection least 2 organ dysfunction define SOFA score =or &gt; 3 least 6 consecutive hour need vasopressor ( dopamine =or &gt; 15µg/kg/min epinephrine/norepinephrine =or &gt; 0,25 µg/kg/min least 6 consecutive hour , maintain systolic arterial pressure 90 mmHg OR mean arterial pressure 6 ( mmHg inform consent pregnancy breath feed decision resuscitate underlying disease estimate life expectancy le 1 month formal indication corticosteroid recent surgery ( ie within past 72 hour ) surgery high risk bleed gastrointestinal bleeding within past 6 week chronic liver disease ( Child C ) recent trauma ( ie within past 72 hour ) intracranial process history stroke , CNS bleed traumatic brain injury within past 3 month platelet count less 30000 per cubic millimeter formal indication curative anticoagulant ; prophylactic use heparin allow condition high risk bleed per patient 's primary physician hypersensitivity activate drotrecogin alpha component drug affiliation social security</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>septic shock</keyword>
	<keyword>coagulation</keyword>
	<keyword>immunomodulation</keyword>
	<keyword>survival</keyword>
</DOC>